Cargando…
A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
Animal models show that systemically administered bone marrow‐derived mesenchymal stem cells (MSCs) home to sites of primary and metastatic prostate cancer (PC)—making them candidates to selectively deliver cytotoxic agents. To further assess this potential as a cell‐based therapeutic vehicle, a pha...
Autores principales: | Schweizer, Michael T., Wang, Hao, Bivalacqua, Trinity J., Partin, Alan W., Lim, Su Jin, Chapman, Carolyn, Abdallah, Rehab, Levy, Oren, Bhowmick, Neil A., Karp, Jeffrey M., De Marzo, Angelo, Isaacs, John T., Brennen, W. Nathaniel, Denmeade, Samuel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477003/ https://www.ncbi.nlm.nih.gov/pubmed/30735000 http://dx.doi.org/10.1002/sctm.18-0230 |
Ejemplares similares
-
In Reply
por: Brennen, W. Nathaniel, et al.
Publicado: (2019) -
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction
por: Rieger, Angela C, et al.
Publicado: (2022) -
Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
por: Wang, Zujia, et al.
Publicado: (2022) -
Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy
por: Golubeva, Diana, et al.
Publicado: (2023) -
Systemic multipotent adult progenitor cells protect the cerebellum after asphyxia in fetal sheep
por: Gussenhoven, Ruth, et al.
Publicado: (2020)